felin
infecti
periton
fip
fatal
diseas
clinic
effect
treatment
field
studi
evalu
treatment
polyprenyl
immunostimul
pi
cat
noneffus
form
fip
immun
suppress
major
compon
patholog
fip
hypothes
treatment
immun
system
stimul
would
increas
surviv
time
cat
dri
fip
sixti
cat
diagnos
dri
fip
primari
care
specialist
veterinarian
meet
accept
criteria
treat
pi
without
intent
select
less
sever
case
surviv
time
start
pi
treatment
cat
diagnos
dri
fip
show
cat
dri
fip
treat
pi
surviv
day
surviv
day
literatur
search
identifi
cat
noneffus
dri
fip
cat
dri
fip
live
longer
day
veterinarian
cat
treat
pi
surviv
day
report
improv
clinic
sign
behavior
surviv
time
studi
significantli
longer
cat
treat
corticosteroid
concurr
pi
cure
pi
show
promis
treatment
dri
form
fip
control
studi
need
verifi
benefit
studi
decisionmak
tree
glanc
product
antibodi
coronaviru
result
deposit
immun
complex
immunosuppress
major
compon
pathophysiolog
treatment
immun
stimul
ration
approach
polyprenyl
immunostimul
pi
veterinari
biolog
licens
u
depart
agricultur
reduct
sever
sign
felin
herpesviru
safe
cat
week
age
use
pilot
studi
treat
cat
dri
form
fip
produc
promis
result
upregul
type
pathway
via
tolllik
receptor
may
thu
benefit
diseas
involv
suppress
cellular
immun
field
studi
tri
determin
pi
treatment
increas
surviv
time
qualiti
life
cat
diagnos
dri
fip
field
studi
singl
treatment
arm
without
placebo
control
group
limit
cat
noneffus
dri
fip
cat
unit
state
canada
accept
cat
diagnos
treat
primari
care
veterinarian
conjunct
mani
case
veterinari
specialist
veterinarian
usual
laboratori
perform
diagnost
test
studi
measur
surviv
time
start
pi
treatment
death
euthanasia
termin
condit
surviv
data
studi
compar
histor
data
number
publish
articl
studi
includ
cat
signal
clinic
sign
repres
clinic
spectrum
dri
form
fip
accept
treat
regardless
sever
diseas
current
treatment
addit
appetit
stimul
antiemet
antibiot
vitamin
special
diet
prohibit
studi
protocol
advis
use
corticosteroid
caus
immunosuppress
studi
carri
accord
recommend
univers
tennesse
offic
laboratori
anim
care
protocol
approv
univers
tennesse
institut
anim
care
use
committe
protocol
preliminari
find
prior
pilot
studi
publish
veterinari
inform
network
site
publish
note
trial
februari
follow
public
articl
note
practic
veterinarian
suspect
confirm
fip
case
contact
princip
investig
aml
via
email
phone
cat
diagnos
dri
fip
veterinarian
consid
assign
number
figur
initi
diagnost
done
veterinarian
review
assess
accept
aml
base
suffici
data
support
diagnosi
eight
instanc
aml
accept
cat
studi
without
laboratori
diagnost
diagnosi
made
invas
techniqu
immunohistochemistri
ihc
histopatholog
biopsi
materi
cytolog
aspir
initi
veterinarian
diagnosi
support
use
diagnost
approach
propos
addi
et
al
reflect
data
collect
form
tabl
includ
question
patient
age
histori
environ
observ
pyrexia
weight
loss
lethargi
anorexia
presenc
abdomin
lesion
mass
enlarg
mesenter
lymph
node
requir
laboratori
test
includ
complet
blood
count
biochemistri
antibodi
titer
felin
coronaviru
fcov
pathogen
may
mimic
fip
surgic
biopsi
aspir
suspect
lesion
encourag
necropsi
offer
univers
tennesse
free
charg
veterinarian
could
provid
result
necropsi
done
provid
accept
cat
receiv
pi
mgkg
oral
three
time
per
week
clinic
assess
veterinarian
initi
followup
examin
monthli
recommend
collect
data
analysi
shown
tabl
submiss
initi
followup
laboratori
test
result
requir
refil
pi
ship
collabor
veterinarian
result
followup
evalu
receiv
monitor
progress
cat
accept
studi
continu
death
euthanasia
veterinarian
advis
taper
corticosteroid
treatment
start
studi
allow
continu
corticosteroid
therapi
lowest
effect
dose
maintain
appetit
wellb
qualiti
life
assess
done
use
respons
questionnair
commun
primari
care
veterinarian
owner
mani
case
extens
comment
record
cat
medic
record
record
analyz
comment
consid
commun
veterinarian
owner
regard
restor
routin
activ
level
appetit
improv
etc
indic
qualiti
life
tabl
show
questionnair
use
provid
data
collect
studi
skew
kurtosi
statist
found
nonnorm
distribut
tempor
variabl
associ
surviv
therefor
nonparametr
statist
employ
yield
infer
base
respect
research
question
betweensubject
comparison
age
group
diseas
group
conduct
use
kruskalw
mannwhitney
utest
addit
mean
sd
median
interquartil
rang
report
give
context
nonparametr
statist
find
kaplanmei
surviv
curv
use
display
cumul
surviv
cat
across
consider
began
march
end
may
total
cat
consid
studi
cat
diagnos
primari
care
veterinarian
cat
met
qualif
criteria
therefor
accept
studi
refer
specialist
includ
veterinari
ophthalmologist
internist
neurologist
ophthalmologist
neurologist
jointli
veterinari
cardiologist
remain
consid
cat
disqualifi
studi
follow
reason
insuffici
diagnost
inform
die
pi
arriv
wet
form
fip
pi
provid
compassion
basi
treatment
stop
one
two
dose
oversea
case
pi
provid
compassion
basi
incorrect
diagnosi
pi
provid
one
two
cat
compassion
basi
cat
lost
followup
veterinarian
never
provid
inform
pi
ship
one
cat
enrol
error
ie
start
treatment
prior
march
accept
cat
evalu
treat
veterinarian
throughout
usa
canada
practic
fewer
cat
diagnos
day
less
start
pi
treatment
remain
cat
diagnos
dri
fip
day
begin
treatment
pi
mean
time
span
diagnosi
treatment
day
cat
die
administr
first
dose
diagnos
day
start
pi
treatment
fiftynin
cat
accept
studi
clinic
sign
fip
list
algorithm
propos
addi
et
al
presenc
clinic
sign
caus
cat
owner
bring
cat
primari
veterinarian
examin
initi
examin
clinic
sign
document
medic
record
figur
b
show
clinic
sign
distribut
cat
accept
studi
fiftyfour
cat
show
two
clinic
sign
figur
five
cat
one
sign
five
cat
one
sign
neurolog
ocular
evalu
persist
vomit
abdomin
mass
ileocol
region
discov
examin
data
comprehens
initi
examin
provid
one
whose
abdomin
mass
discov
physic
examin
one
cat
includ
studi
clinic
sign
seen
neuter
male
siberian
cat
gdl
serum
total
protein
preanesthesia
screen
albumin
gdl
globulin
ag
ratio
serum
electrophoresi
interpret
polyclon
gammopathi
cat
anem
hematocrit
coronaviru
antibodi
titer
posit
felin
leukemia
antigen
neg
felin
immunodefici
antibodi
titer
neg
thorac
radiograph
show
increas
cranial
mediastin
densiti
enlarg
mesenter
lymph
node
seen
abdomin
ultrasound
lymph
node
aspir
show
increas
neutrophil
aspir
cytolog
fiftynin
cat
studi
categor
one
five
subform
dri
fip
base
initi
clinic
sign
physic
examin
find
primari
veterinarian
specialist
applic
diagnost
workup
one
cat
clinic
sign
subform
categori
distribut
follow
mix
gastrointestin
nonloc
ocular
neurolog
initi
present
cat
gastrointestin
categori
anorexia
diarrhea
andor
vomit
primari
reason
veterinari
visit
abdomin
mass
found
cat
studi
cat
categor
either
gastrointestin
mix
subform
depend
whether
addit
clinic
sign
often
associ
anoth
subform
ocular
chang
report
cat
includ
anterior
uveiti
retin
detach
kerat
precipit
one
cat
corneal
ulcer
cat
ocular
sign
reason
initi
veterinari
visit
cat
assign
ocular
subform
cat
ocular
sign
also
neurolog
abdomin
nonloc
sign
classifi
mix
form
neurolog
sign
seizur
ataxia
disorient
main
reason
veterinari
evalu
cat
categor
neurolog
subform
nonloc
categori
includ
cat
persist
fever
uncontrollablewithantibiot
lethargi
anorexia
andor
weight
loss
mix
subform
cat
simultan
sign
two
subcategori
ocular
combin
neurolog
sign
eg
uveiti
seizur
result
hematolog
test
blood
drawn
initi
examin
shown
tabl
blood
test
data
unavail
nine
cat
initi
diagnos
base
histolog
cytolog
find
consist
fip
accept
diagnost
two
cat
serolog
hematolog
test
done
accept
start
treatment
later
data
includ
tabl
case
test
includ
item
interest
thu
data
set
complet
jaundic
observ
one
cat
wherea
hyperbilirubinemia
note
cat
anemia
hct
observ
cat
increas
wbc
count
note
neutrophilia
observ
lymphopenia
cat
hyperglobulinemia
andor
albuminglobulin
ag
ratio
note
cat
two
cat
ag
ratio
equal
mean
sd
valu
whole
group
spread
shown
tabl
antibodi
titer
test
ifa
cat
scale
propos
addi
et
al
rank
high
posit
n
high
posit
n
titer
two
cat
low
posit
titer
diagnosi
confirm
immunostain
biopsi
lesion
fcov
antigen
elisa
use
three
cat
pcr
test
done
three
cat
show
neg
result
two
two
cat
retest
ifa
posit
result
also
diagnosi
cytolog
collect
data
set
differenti
test
cat
test
includ
felv
antigen
felin
immunodefici
viru
fiv
toxoplasma
except
one
cat
fiv
posit
test
result
neg
serolog
data
avail
cat
group
probabl
diagnosi
four
miss
data
set
one
cat
diagnos
neurologist
base
result
spinal
tap
mri
anoth
one
uveiti
lb
main
coon
kitten
group
diagnosi
confirm
histolog
cytolog
immunochem
method
six
cat
without
differenti
data
set
four
diagnos
ihc
two
histolog
biopsi
tissu
special
laboratori
test
method
use
confirm
dri
fip
diagnosi
summar
tabl
histolog
cytolog
perform
cat
conclus
valid
immunostain
fcov
antigen
cat
one
cat
pyogranulomat
mesenter
lymphadenopathi
lymph
node
aspir
also
elev
fcov
transcript
rtpcr
test
sampl
three
cat
neurolog
diseas
diagnosi
confirm
csf
tap
two
mri
result
consist
fip
diagnosi
one
cat
ocular
form
ocular
centesi
follow
quantit
pcr
confirm
presenc
high
titer
fcov
subgenom
mrna
gene
necropsi
done
cat
necropsi
done
cat
whose
diagnosi
previous
confirm
antemortem
histolog
cytolog
histopatholog
analysi
necropsi
tissu
conclus
fip
cat
inconclus
survivor
cat
accept
field
studi
receiv
pi
treatment
cat
receiv
treatment
enrol
andor
concurr
pi
includ
one
appetit
stimul
antiemet
antibiot
corticosteroid
vitamin
andor
special
diet
data
concurr
treatment
two
cat
sixtytwo
percent
cat
prescrib
corticosteroid
oral
time
initi
diagnosi
topic
ocular
cat
corticosteroid
treatment
stop
shortli
begin
treatment
pi
statist
use
corticosteroid
present
tabl
studi
cat
receiv
corticosteroid
concurr
pi
ocular
topic
system
system
ocular
topic
cat
treat
pi
without
concurr
corticosteroid
four
cat
whose
corticosteroid
treatment
stop
complianc
request
test
protocol
start
pi
treatment
clinic
sign
consist
fip
weight
loss
ataxia
abdomin
mass
pyrexia
lethargi
anorexia
number
clinic
sign
laboratori
test
also
support
diagnosi
two
veterinarian
start
corticosteroid
treatment
cat
deterior
one
one
day
death
case
endoflif
care
count
corticosteroid
receiv
one
cat
given
one
dose
nelfinavir
day
die
veterinarian
owner
durat
surviv
determin
time
start
pi
treatment
death
euthanasia
cat
treat
pi
surviv
day
cat
surviv
day
cat
surviv
day
one
addit
cat
surviv
day
count
day
cat
day
surviv
time
cat
three
group
ie
treat
oral
corticosteroid
concurr
pi
treat
topic
ocular
corticosteroid
concurr
pi
treat
pi
without
concurr
use
corticosteroid
significantli
differ
p
kruskalw
test
tabl
list
statist
data
surviv
curv
present
figur
cat
receiv
corticosteroid
median
surviv
time
day
n
cat
receiv
corticosteroid
rout
concurr
pi
median
surviv
time
day
n
differ
surviv
time
group
corticosteroid
receiv
versu
nonreceiv
signific
p
mannwhitney
utest
signific
differ
surviv
time
cat
treat
corticosteroid
system
topic
p
mannwhitney
utest
four
cat
whose
initi
corticosteroid
treatment
stop
treatment
pi
surviv
day
data
concurr
treatment
avail
two
cat
diagnos
histolog
histolog
ihc
cat
receiv
pi
alon
whose
diagnosi
confirm
cytolog
histolog
anteor
postmortem
surviv
time
day
day
median
day
n
cat
treat
pi
corticosteroid
concurr
pi
surviv
day
day
median
day
n
differ
surviv
cat
treat
untreat
corticosteroid
concurr
pi
signific
p
cat
whose
diagnosi
confirm
type
analysi
biopsi
necropsi
sampl
treat
pi
without
concurr
corticosteroid
surviv
day
day
median
day
n
cat
treat
pi
corticosteroid
concurr
surviv
day
day
median
day
n
two
cat
inconclus
result
cytolog
necropsi
account
unconfirm
method
differ
surviv
cat
treat
untreat
corticosteroid
concurr
pi
signific
p
subgroup
diagnosi
also
confirm
ihc
includ
eight
cat
treat
pi
surviv
day
four
cat
treat
pi
concurr
corticosteroid
surviv
day
concurr
treatment
data
avail
one
cat
surviv
one
day
size
subgroup
insuffici
render
statist
power
analysi
signific
differ
surviv
time
group
treat
pi
diagnos
without
biopsybas
test
n
versu
diagnos
biopsybas
test
n
p
mannwhitney
utest
similarli
differ
surviv
time
group
treat
corticosteroid
concurr
pi
diagnos
tissu
biopsi
n
without
n
p
mannwhitney
utest
signific
differ
found
surviv
time
cat
receiv
oral
n
topic
ocular
corticosteroid
n
p
mannwhitney
utest
median
surviv
time
day
respect
signific
differ
note
surviv
time
cat
differ
subform
diseas
regardless
use
steroid
tabl
surviv
time
cat
belong
age
group
month
month
differ
significantli
p
kruskalw
test
begin
treatment
noneffus
form
progress
effus
six
cat
five
die
euthan
within
week
thereaft
one
cat
whose
initi
corticosteroid
treatment
stop
begin
pi
trial
develop
palpabl
abdomin
mass
effus
month
treatment
resolv
next
monthli
visit
month
treatment
small
mass
palpat
small
amount
fluid
midcrani
abdomen
identifi
per
veterinarian
record
mass
remain
unchang
next
two
monthli
visit
cat
develop
distend
belli
palpabl
fluid
eighth
month
pi
treatment
amount
fluid
decreas
next
monthli
check
month
treatment
cat
clinic
well
gain
weight
return
normal
routin
play
appetit
cat
start
declin
ninth
month
pi
treatment
lost
weight
increas
amount
abdomin
fluid
cat
die
natur
day
start
treatment
three
cat
ocular
diseas
surviv
day
initi
sign
includ
anterior
uveiti
kerat
precipit
discolor
anisocortia
two
cat
anterior
uveiti
significantli
improv
resolv
month
pi
treatment
corticosteroid
uveiti
improv
one
cat
receiv
topic
ocular
corticosteroid
concurr
pi
eye
enucl
cat
palpabl
abdomin
mass
surviv
day
life
span
day
reduct
resolut
abdomin
mass
note
first
second
monthli
followup
examin
three
six
cat
receiv
corticosteroid
togeth
pi
one
six
cat
describ
whose
initi
neurolog
sign
resolv
palpabl
mass
longer
report
month
treatment
redevelop
small
palpabl
abdomin
mass
abdomin
fluid
month
treatment
month
prior
natur
death
day
corticosteroid
treatment
cat
stop
pi
treatment
began
anoth
cat
receiv
corticosteroid
mass
initi
resect
reappear
month
prior
euthanasia
day
mass
remain
unchang
palpat
cat
four
cat
receiv
corticosteroid
treatment
find
confirm
ultrasound
test
one
four
two
cat
die
followup
examin
followup
data
avail
one
cat
four
cat
surviv
day
consid
long
term
survivor
record
scrutin
consider
detail
death
summari
data
cat
present
initi
veterinarian
sign
typic
dri
fip
includ
inappet
lethargi
weight
loss
one
cat
persist
diarrhea
vomit
two
four
cat
abdomin
mass
detect
veterinarian
ag
ratio
four
cat
rang
three
four
cat
anem
moder
high
coronaviru
antibodi
titer
kelisa
three
ifa
two
four
cat
histopatholog
biopsi
tissu
pyogranulomat
inflamm
diagnosi
valid
immunostain
fcov
antigen
cat
longest
survivor
day
initi
receiv
prednisolon
control
weight
loss
corticosteroid
therapi
discontinu
start
pi
treatment
base
report
owner
veterinarian
four
cat
return
normal
behavior
first
checkup
visit
month
begin
treatment
weight
either
stabil
increas
clinic
sign
vomit
diarrhea
lethargi
etc
also
resolv
three
cat
lost
weight
death
data
unavail
one
ag
ratio
increas
month
pi
treatment
two
longest
survivor
reach
anemia
improv
one
resolv
anoth
one
borderlin
anemia
although
somewhat
improv
present
cat
survivor
becam
pronounc
death
treatment
stop
day
cat
laboratori
test
data
avail
time
death
day
necropsi
perform
pi
treatment
frequenc
taper
first
twice
weekli
weekli
cat
cat
euthan
extremi
necropsi
cat
show
lesion
consist
fip
necropsi
cat
show
lymphoplasmacyt
interstiti
nephriti
cystiti
cystica
without
lesion
fip
toxicosi
azotemia
ischemia
probabl
associ
renal
failur
led
euthanasia
cat
ultrasound
show
mass
intern
organ
result
unremark
necropsi
perform
number
veterinarian
owner
voluntarili
provid
inform
qualiti
life
commun
veterinarian
comment
first
recheck
day
pi
treatment
use
questionnair
qualityofliferel
comment
record
veterinarian
medic
record
analyz
found
improv
qualityoflif
comment
cat
surviv
day
comment
cat
indic
improv
perceiv
qualiti
life
return
normal
diseas
appear
healthi
got
back
normal
routin
andor
improv
appetit
mobil
social
respons
preced
period
commonli
everi
month
treatment
weight
stabil
increas
patient
continu
lose
weight
show
improv
behavior
appetit
toxic
advers
event
due
administr
pi
report
veterinarian
owner
report
cat
presum
noneffus
fip
diagnos
use
recogn
algorithm
treat
pi
cat
surviv
day
cat
day
cat
surviv
day
day
one
surviv
day
live
day
start
treatment
cat
given
oral
corticosteroid
receiv
topic
ocular
corticosteroid
concurr
pi
surviv
mean
day
day
median
day
cat
treat
pi
without
corticosteroid
surviv
mean
day
day
median
day
significantli
longer
tabl
figur
current
common
therapi
fip
corticosteroid
cat
start
corticosteroid
time
diagnosi
treatment
stop
cat
start
pi
continu
corticosteroid
concurr
pi
four
cat
whose
corticosteroid
treatment
stop
surviv
mean
day
day
median
day
four
cat
multipl
sign
diseas
none
four
cat
time
diagnosi
appear
less
sever
affect
cat
studi
subgroup
fip
differ
likelihood
corticosteroid
use
gi
subform
fip
receiv
corticosteroid
neurolog
subform
receiv
corticosteroid
topic
ocular
corticosteroid
appear
reduc
surviv
time
given
concurr
pi
figur
accept
cat
met
inclus
criteria
intent
select
less
sever
case
studi
assess
sever
diseas
done
first
assumpt
corticosteroid
use
sever
case
could
find
justif
assumpt
small
sampl
size
allow
rule
shorter
surviv
time
cat
concurr
treat
pi
corticosteroid
may
indirectli
reflect
sever
diseas
observ
statist
signific
differ
surviv
cat
either
subform
diseas
ocular
neurolog
gastrointestin
nonloc
mix
differ
age
group
month
month
month
month
may
wide
varianc
group
suffici
number
cat
group
statist
power
valid
conclus
literatur
offer
limit
data
surviv
time
cat
dri
form
fip
without
treatment
cat
literatur
dri
form
fip
treat
corticosteroid
support
care
surviv
rang
day
n
one
earli
studi
examin
field
record
intestin
granulomat
manifest
n
report
surviv
time
noneffus
fip
form
month
cat
lost
followup
care
retrospect
record
studi
report
surviv
time
day
cat
histolog
confirm
diagnosi
effus
noneffus
separ
data
provid
day
n
report
clinic
studi
natur
infect
put
surviv
dri
fip
day
n
day
n
day
without
treatment
n
day
cat
previous
given
fip
vaccin
prevent
n
literatur
mention
individu
cat
diagnos
dri
form
surviv
day
glucocorticoid
treatment
two
cat
surviv
day
mix
drywet
form
treat
glucocorticoid
human
nelfinavir
recent
mention
natur
surviv
time
year
without
treatment
cat
dri
form
fip
refer
cat
treat
pi
surviv
time
studi
compar
publish
data
cat
dri
form
fip
data
suggest
lengthen
surviv
time
cat
treat
pi
surviv
time
equal
exceed
longest
surviv
time
report
literatur
dri
fip
cat
studi
exceed
maximum
report
number
day
diagnosi
dri
fip
field
studi
done
differ
level
diagnost
certainti
compar
surviv
time
subgroupsdiagnos
histolog
cytolog
immunostain
test
found
statist
signific
differ
base
proof
diagnosi
although
signific
differ
cat
treat
corticosteroid
concurr
pi
signific
differ
surviv
time
cat
receiv
steroid
regardless
whether
diagnos
biopsybas
method
diagnos
without
invas
method
surviv
time
regardless
diagnost
method
use
comparison
mean
sd
valu
surviv
time
cat
dri
fip
show
surviv
time
cat
studi
significantli
longer
group
treat
pi
without
concurr
corticosteroid
treatment
day
n
publish
day
n
p
surviv
time
group
treat
corticosteroid
concurr
pi
day
n
significantli
differ
p
publish
valu
corticosteroid
usual
treatment
fip
sign
howev
need
use
caution
pi
use
felin
infecti
periton
consid
fatal
studi
plan
preclud
ethic
reason
experiment
design
use
untreat
placebo
group
statist
comparison
data
placebo
group
ideal
studi
model
human
studi
use
singlearm
trial
anticanc
drug
surviv
endpoint
studi
placebo
best
accept
therapi
use
lack
known
benefici
treatment
univers
grave
prognosi
studi
field
trial
depend
primari
care
veterinarian
identifi
candid
studi
treat
accept
accord
protocol
ethic
ground
consid
reluct
cat
owner
particip
placebocontrol
studi
elect
present
studi
design
decis
exclud
cat
wet
form
fip
base
rapid
progress
wet
form
median
day
assum
correctli
faster
expect
median
time
need
accept
cat
studi
turn
pi
effus
fip
appear
promis
treatment
dri
form
fip
encourag
diagnosi
dri
fip
done
three
level
certainti
highli
probabl
diagnosi
support
histori
clinic
sign
laboratori
find
without
special
lab
test
categori
includ
neurolog
form
biopsi
possibl
ocular
form
ocular
centesi
use
histolog
cytolog
confirm
diagnosi
without
immunostain
group
also
includ
cat
confirm
done
necropsi
tissu
subgroup
confirm
presenc
fcov
antigen
ihc
statist
signific
differ
surviv
cat
diagnos
differ
certainti
level
treat
pi
could
compar
surviv
time
subgroup
treat
corticosteroid
due
insuffici
sampl
power
make
antemortem
diagnosi
dri
fip
notori
hard
absenc
singl
standard
test
reli
combin
nonspecif
diseaseind
especi
owner
allow
invas
procedur
test
data
clinic
chemistri
hematolog
serolog
clinic
assess
histolog
etc
differ
predict
valu
pathognomon
absenc
singl
reliabl
diagnost
approach
diagnost
effort
aim
increas
index
suspicion
call
diaz
poma
requir
gold
standard
vari
research
group
accept
histopatholog
other
stress
ihc
consensu
document
addi
et
al
avoid
definit
definit
diagnosi
altogeth
clinic
practic
diagnos
made
laboratori
find
consist
fip
exclud
diseas
primari
care
veterinarian
veterinari
specialist
treat
cat
comfort
diagnosi
dri
form
fip
use
term
presumpt
fip
gold
standard
coronaviru
antigen
ihc
lesion
consist
dri
form
fip
achiev
cat
cat
studi
diagnos
veterinarian
base
assess
combin
signal
clinic
sign
mani
test
necessari
rule
diseas
support
diagnosi
reli
experi
mode
document
rohrbach
et
al
diagnosi
made
primari
care
veterinarian
conjunct
specialist
need
review
aml
use
criteria
consist
evidencebas
algorithm
special
test
histolog
cytolog
csf
tap
pcr
aqueou
humor
ihc
necropsi
done
cat
presumpt
diagnosi
made
owner
often
reluct
get
confirm
invas
procedur
diagnosi
cat
studi
establish
individu
also
compar
data
data
publish
cat
confirm
diagnosi
fip
signal
hous
densiti
similar
report
data
major
cat
young
nonpedigre
origin
multicat
household
age
distribut
fip
patient
studi
underscor
wellestablish
age
bia
fip
clinic
present
observ
sampl
similar
report
cat
dri
form
fip
diseas
may
clinic
similar
fip
exclud
specif
test
cat
felin
leukemia
viru
felv
antigen
fiv
antibodi
measur
cat
one
posit
fiv
antibodi
fip
diagnosi
fivposit
cat
given
neurologist
base
result
mri
csf
tap
antibodi
toxoplasma
measur
cat
neg
ten
cat
test
felv
fiv
six
diagnosi
confirm
special
test
biopsi
tissu
four
ihc
two
histolog
four
number
strong
fip
indic
consid
presumpt
analyz
initi
biochem
paramet
diagnost
valu
fip
young
cat
high
serum
globulin
low
ag
ratio
condit
except
fip
like
plasma
cell
blymphocyt
malign
produc
monoclon
gammopathi
condit
rare
young
cat
chronic
inflammatori
infecti
condit
chronic
abscess
pyothorax
could
increas
serum
globulin
level
condit
would
like
identifi
diagnost
evalu
hyperglobulinemia
andor
albuminglobulin
ag
ratio
note
cat
two
cat
ag
ratio
equal
initi
evalu
cat
studi
hyperglobulinemia
cat
similar
valu
report
literatur
combin
wetdri
group
albuminglobulin
ratio
offer
highest
posit
predict
valu
fip
group
consist
report
valu
fip
gener
lower
mean
sd
report
initi
present
tsai
et
al
hyperbilirubinemia
occur
cat
consist
dri
form
fip
lower
report
group
wet
fip
hyperglobulinemia
import
diagnost
sign
rare
associ
diseas
fip
young
kitten
often
affect
group
initi
hematolog
paramet
diagnost
valu
fip
analyz
leukocytosi
neutrophilia
found
cat
respect
valu
consist
publish
lymphopenia
present
studi
cat
consist
previou
studi
coronaviru
antibodi
titer
somewhat
help
diagnosi
fip
neg
serum
antibodi
titer
make
diagnosi
fip
unlik
high
high
titer
support
diagnosi
howev
midrang
high
antibodi
titer
occur
coronaviru
infect
without
fip
test
cat
accept
studi
coronaviru
antibodi
titer
cat
high
n
high
n
extrem
high
posit
titer
n
cat
studi
without
sign
fip
diagnos
veterinarian
preneut
checkup
followup
cytolog
mesenter
lymph
node
aspir
inconclus
cellular
insuffici
definit
demonstr
pyogranulomat
inflamm
although
evid
neoplasia
infecti
organ
cat
develop
effus
die
day
treatment
pi
corticosteroid
concurr
four
cat
surviv
day
clinic
sign
diagnost
test
consist
fip
initi
examin
detail
histori
diagnost
inform
given
tabl
figur
although
cat
histopatholog
ihc
age
month
exposur
multicat
fcov
environ
clinic
sign
laboratori
find
high
fcov
antibodi
titer
suffici
establish
clinic
diagnosi
cat
diagnos
confirm
histolog
cytolog
ihc
four
show
clinic
improv
return
normal
behavior
cat
modest
improv
laboratori
find
despit
clinic
improv
figur
b
clinic
declin
two
cat
start
week
death
accompani
weight
loss
anorexia
worsen
anemia
reappear
abdomin
mass
resect
site
cat
pleural
effus
cat
redevelop
abdomin
mass
progress
diseas
common
cat
mass
resect
two
longest
survivor
cat
weight
loss
diagnosi
gain
weight
pi
treatment
weight
gain
cat
start
week
trial
attribut
prednisolon
mg
daili
prednisolon
treatment
taper
stop
first
week
pi
treatment
cat
continu
gain
weight
clinic
improv
weight
gain
cat
accompani
improv
ag
ratio
hematocrit
figur
c
cat
pi
treatment
either
stop
frequenc
decreas
year
surviv
cat
die
renal
failur
cat
declin
end
life
euthan
extremi
lack
pyogranulomat
chang
biopsi
tissu
cat
consist
observ
cat
experiment
infect
fipv
clinic
diseas
surviv
free
lesion
postmortem
necropsi
chang
mild
hepat
firbrosi
mild
chronic
lymphoplasmacyt
interstiti
nephriti
adequ
account
demis
cat
evid
lesion
fip
ag
ratio
initi
diagnosi
return
normal
suggest
resolut
fip
necropsi
perform
cat
use
formal
assess
qualiti
life
collect
inform
clinic
behavior
chang
progress
report
commun
veterinarian
chart
progress
report
note
indic
improv
qualiti
life
return
normal
prediagnosi
behavior
express
comment
owner
veterinarian
eg
energet
well
act
normal
etc
medic
record
cat
note
energi
play
interact
owner
essenti
return
prefip
behavior
cat
live
day
clinic
improv
ie
improv
one
sign
increas
appetit
abat
fever
anecdot
note
day
four
six
dose
pi
report
weight
gain
report
weight
loss
weight
remain
stabl
cat
record
file
cat
gener
speak
cat
treat
pi
return
regular
routin
occasion
bad
day
precipit
declin
led
death
euthanasia
within
day
result
suggest
pi
benefit
cat
clinic
diagnos
dri
fip
increas
surviv
time
improv
qualiti
life
control
studi
need
verifi
benefit
pi
treatment
fip
cure
pi
may
maintain
fip
cat
chronic
condit
oppos
fastprogress
fatal
diseas
may
possibl
predict
monitor
surviv
normal
ag
ratio
hematocrit
surviv
time
pi
treatment
significantli
longer
corticosteroid
use
concurr
author
contribut
al
concept
design
work
interpret
data
revis
manuscript
critic
import
intellectu
content
final
approv
version
publish
tk
poststudi
acquisit
data
analysi
interpret
data
work
draft
work
revis
critic
import
intellectu
content
final
approv
version
publish
gg
data
acquisit
entri
organ
final
approv
version
publish
vb
data
acquisit
entri
organ
revis
data
manuscript
critic
import
intellectu
content
final
approv
version
publish
rh
data
analysi
interpret
revis
manuscript
critic
import
intellectu
content
final
approv
version
publish
author
agre
account
aspect
work
ensur
question
relat
accuraci
integr
part
work
appropri
investig
resolv
work
done
univers
tennesse
collabor
cat
owner
veterinarian
thank
owner
cat
veterinarian
particip
studi
winn
felin
foundat
grant
al
support
partial
salari
gg
technic
support
sass
sass
inc
provid
polyprenyl
immunostimul
nonmonetari
support
collect
analyz
data
owner
cat
financi
respons
diagnost
monitor
cost
